BioStack Platforms YC Application

Spring 2026Active

BioStack Platforms went through Y Combinator in the Spring 2026 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.

YC batch: Spring 2026
Industry: Healthcare
Status: Active
Launched: 2026

Founders

Sanat MishraFounder
Parth PatwaFounder

What BioStack Platforms does

BioStack is building the data engine for healthcare and drug discovery AI. The bottleneck is not models. It is access to high-quality biological data. Clinical and experimental data is fragmented, unstructured, and locked inside hospitals, labs, and CROs, while generating new data is slow and expensive. BioStack fixes this with proprietary clinical and preclinical data pipelines that turn real biomedical workflows into ML-ready training environments. We structure longitudinal multimodal data across imaging, EHR, and experimental assays, then package it for post-training and reinforcement learning so models can learn how research and care actually happen. Instead of static datasets, BioStack gives AI labs workflow-aligned data and environments that improve reasoning, decision-making, and real-world performance in biology and medicine.

BioStack Platforms's YC application, reconstructed

Y Combinator application

BioStack Platforms, Spring 2026 batch. The real form questions, answered from public data.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

BioStack Platforms

Describe what your company does in 50 characters or less.

Real world training envs for healthcare AI models

What is your company going to make? Please describe your product and what it does or will do.

We build data pipelines that turn messy, fragmented clinical and experimental biology data into structured, machine learning-ready training environments. Our platform aligns longitudinal multimodal data - from imaging, EHR, and experimental assays - into workflows that reflect actual biomedical research and clinical care. This lets AI models train not just on static datasets but on sequences of real-world biomedical workflows, improving their decision-making and reasoning in healthcare and drug discovery.

Where do you live now, and where would the company be based after YC?

We live in San Francisco, CA, and plan to keep the company based here after YC.

Explain your decision regarding location.

San Francisco has the expertise in AI and biotech we need, plus proximity to hospitals and labs where data originates. It gives us the network and talent to build and scale BioStack.

21 more answers in the full application

Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.

See full application

Frequently Asked Questions

Is this the real BioStack Platforms YC application?

No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from BioStack Platforms's public data (launch notes, founder backgrounds, product description). It shows how a company like BioStack Platforms would present itself to YC, not the text they submitted.